Heart disease is among the leading causes of death in the United States, and most of the work of managing it happens between office visits. Telehealth in cardiology brings that work into the home through video visits, remote patient monitoring (RPM) and hybrid care models that combine both. The evidence base has grown considerably since the pandemic, and Medicare policy has settled enough that cardiology practices can plan with more confidence than they could a few years ago.
This article covers what telehealth in cardiology includes and what peer-reviewed research says about effectiveness. It looks at access for rural and underserved patients, the cost picture, and where Medicare policy stands in late 2026. It closes with implementation steps for cardiology practices and answers to six common questions.
What Telehealth in Cardiology Covers
Telehealth in cardiology is broader than a video call with a cardiologist. It includes video visits for follow-up, medication titration and symptom review. It includes remote patient monitoring, where connected devices capture blood pressure, weight, pulse oximetry and heart rhythm at home and transmit those readings to the care team. And it includes hybrid models, where in-person visits for imaging, procedures and physical exams sit alongside virtual touchpoints for everything else.
The monitored measurements map directly to the conditions cardiology manages most often. Daily weight and oxygen saturation support heart failure care, where fluid gain often shows up on a scale days before symptoms appear. Home blood pressure readings support hypertension management, which is the single largest modifiable driver of cardiovascular risk. Heart rhythm data, whether from a single-lead ECG device or a wearable, supports arrhythmia detection and follow-up after ablation or cardioversion. Cardiac care at home depends on these readings arriving reliably and being reviewed by someone who can act on them.
Hybrid care is where most programs land. A patient with heart failure might see a cardiologist in person twice a year, complete video visits with a nurse practitioner between those appointments, and step on a connected scale every morning. Each layer covers a gap the others leave open.
Evidence That Telehealth in Cardiology Works
The American Heart Association reviewed the research in a 2022 scientific statement published in Circulation. The statement concluded that telehealth is an effective way to educate, diagnose, monitor and follow up with people who have cardiovascular disease, and that remote monitoring through portals, smart devices and wearables may be cost-effective for hypertension, heart failure and coronary artery disease. The AHA statement also named the obstacles: broadband gaps, variable reimbursement, state licensing differences and limited infrastructure for analyzing incoming data.
The strongest randomized evidence for heart failure telemonitoring comes from TIM-HF2, published in The Lancet in 2018. The trial randomized 1,571 patients with heart failure and a recent hospitalization to structured remote patient management or usual care. Patients in the remote arm transmitted daily weight, blood pressure, heart rate, heart rhythm and oxygen saturation to a telemedical center staffed around the clock. According to the ACC summary of the Lancet paper, the remote group lost 4.88 percent of days to unplanned cardiovascular hospitalization or death, compared with 6.64 percent in usual care. All-cause mortality was 7.86 versus 11.34 deaths per 100 person-years, a hazard ratio of 0.70.
More recent real-world data point the same direction. The TELESAT-HF study, published in the European Journal of Heart Failure in 2025, followed 5,357 heart failure patients enrolled in a national remote monitoring program in France and compared them with 13,525 propensity-weighted patients receiving standard care. Over a median follow-up of roughly two and a half years, the remote monitoring group had a 36 percent lower risk of all-cause death (hazard ratio 0.64) and 17 percent fewer emergency visits. The TELESAT-HF authors did not find a significant reduction in heart failure hospitalizations, which is a fair reminder that observational results need randomized confirmation.
Hypertension telemonitoring has its own 2025 evidence. A peer-reviewed study in JMIR Cardio analyzed 2,206 patients referred to UC San Diego Health’s team-based digital monitoring program, in which patients used connected blood pressure cuffs and a central team adjusted treatment. Patients with hypertension alone saw an average systolic reduction of about 9.8 mmHg beyond what usual care would predict, and active participants who submitted home readings saw reductions of 13 to 17 mmHg depending on their comorbidity group. The JMIR Cardio analysis also found benefit in patients with diabetes or ischemic heart disease alongside hypertension, which describes a large share of any cardiology panel.
Telehealth in Cardiology and Access for Rural and Underserved Patients
Telehealth in cardiology matters most where cardiologists are scarce. CDC analysis of potentially preventable deaths found that rural counties had the highest percentage of early deaths from heart disease in 2022, and that rural residents face a higher risk of dying early from heart disease than urban residents. The CDC tracked this pattern across 2010 to 2022 and found the rural gap persisted throughout the period.
Workforce data explain part of the problem. According to HRSA, about 20 percent of the U.S. population lives in a primary care Health Professional Shortage Area as of August 2026. Specialty access is thinner still. A patient in a shortage area who develops heart failure often faces a long drive for every follow-up, and each missed or delayed visit raises the chance of decompensation.
Virtual visits and remote monitoring shorten that distance, but only if the technology reaches the patient. A 2026 set of viewpoints in JACC: Advances, summarized by the ACC, warned that digital health built on broadband, smartphones and digital literacy can widen gaps in rural and underserved communities. The authors pointed to SIM-enabled medical devices that connect directly to cellular networks as a practical way to extend remote monitoring to patients who lack home internet or a smartphone. That design choice decides who a program can actually serve. The same point applies to remote monitoring for heart disease: the patients with the most to gain are often the ones least likely to have Wi-Fi.
Cost: Hospitalizations and Readmissions
The cost case for telehealth in cardiology rests on avoided acute care. Heart failure is a reliable place to start. AHRQ’s Healthcare Cost and Utilization Project ranked heart failure second among all principal diagnoses for 30-day all-cause readmissions in 2018, with 233,100 readmissions and a readmission rate of 22.8 per 100 index admissions. Among Medicare patients alone, AHRQ counted 178,000 heart failure readmissions at a rate of 22.9 per 100. Roughly one in five heart failure admissions leads to another within a month.
Telemonitoring targets exactly that window. In TIM-HF2, patients in the remote arm lost fewer days to unplanned cardiovascular hospitalization or death over a year of follow-up. TELESAT-HF reported a 2.1 percent reduction in total time spent in hospital and 17 percent fewer emergency visits in the monitored group. Neither study is a billing analysis, and neither should be read as a guarantee. They do show that when readings arrive daily and someone acts on them, fewer patients end up in the emergency department. For hypertension, the savings are slower and spread over years as sustained blood pressure control lowers long-term cardiovascular risk.
Medicare Telehealth Policy Status in Late 2026
Cardiology practices planning virtual visits need to know what Medicare allows. According to the CMS telehealth FAQ updated in October 2026, the major pandemic-era flexibilities remain in effect through December 31, 2027. Beneficiaries may receive Medicare telehealth services anywhere in the United States, including at home, without the pre-pandemic geographic and originating-site restrictions. Audio-only visits in the home remain covered through the same date. Rural health clinics and federally qualified health centers may continue serving as distant sites. The CMS FAQ also notes that, absent further legislation, most of these flexibilities revert on January 1, 2028, when non-behavioral telehealth would again require the beneficiary to be in a medical facility in a rural area.
Separately, the Calendar Year 2026 Physician Fee Schedule final rule made several telehealth changes permanent. CMS adopted a definition of direct supervision that allows real-time audio and video presence and applied it to cardiac rehabilitation among other services. CMS also simplified how services are added to the Medicare Telehealth Services List and removed frequency limits on certain inpatient and nursing facility follow-up visits. The 2026 fee schedule fact sheet summarizes these changes.
Remote patient monitoring is covered under its own Medicare rules, which CMS describes separately from telehealth visits in its telehealth booklet for providers. RPM requirements center on electronic collection and automatic upload of physiologic data rather than a live two-way encounter. Policy details change annually, and practices should check the CMS telehealth page before each plan year rather than relying on a secondhand summary.
Implementation Steps for Cardiology Practices
The American College of Cardiology published a remote patient management workbook in 2024 to help cardiovascular care teams set up programs. The ACC workbook covers device selection, staffing, workflow integration and the role of AI, and it emphasizes medical-grade accuracy and EHR interoperability as the features clinicians want most. A practical sequence for a cardiology practice looks like this.
- Define the patient population. Start with one condition, usually heart failure or uncontrolled hypertension, and tie enrollment criteria to clinical risk.
- Choose the measurements and thresholds. Decide which readings matter, what range is expected and what triggers a call. Document the escalation path before the first device ships.
- Pick devices patients can actually use. Readings that never arrive help no one. Cellular-connected devices with no app or pairing step remove the most common point of failure for patients 65 and up and for anyone without home internet.
- Assign the monitoring role. Someone has to review the dashboard every working day, usually a nurse or medical assistant with a defined protocol and a cardiologist available for escalation.
- Build the hybrid visit schedule. Pair the data stream with a cadence of video and in-person visits so readings lead to decisions.
- Measure outcomes from the start. Track blood pressure control, weight-triggered interventions, emergency visits and readmissions so the program can show its value in its own numbers.
RPM in cardiology works when the loop between device, reviewer and clinician closes quickly. Patients stay enrolled when they can see that their readings change their care. A program that cannot show that connection will lose participants within a few months.
How Cellular-Connected Devices Fit
Every outcome study above depends on one thing: readings that reach the care team. TIM-HF2 and TELESAT-HF both relied on regular data from home, and the JMIR Cardio hypertension results were largest among patients who actually submitted readings. Device design determines how many patients make it into that group.
Tenovi blood pressure monitors, weight scales and pulse oximeters send readings through the Tenovi Cellular Gateway. There is no app to download, no Bluetooth pairing and no Wi-Fi requirement. A patient takes a reading the same way they would with any home device, and the measurement arrives in the care team’s platform within seconds. That removes the digital literacy and broadband barriers the AHA statement and the JACC: Advances authors identified. Heart failure monitoring with a cellular scale means the daily weight shows up whether or not anyone set up a home router. Tenovi handles fulfillment, provisioning and support, so the practice team can focus on reviewing data and adjusting care.
Frequently Asked Questions About Telehealth in Cardiology
This section answers common questions about telehealth in cardiology from care teams, practice leaders and program managers. Many of them are evaluating or expanding a virtual cardiology program for the first time. The answers draw on the research and policy sources cited above.
1) What does telehealth in cardiology include?
Telehealth in cardiology includes video visits with cardiologists and advanced practice providers, remote patient monitoring of blood pressure, weight, oxygen saturation and heart rhythm, and hybrid models that combine virtual and in-person care. Some programs also include virtual cardiac rehabilitation and remote review of implanted device data. The common thread is that clinical information and decisions move between visits instead of waiting for the next appointment.
2) Is telehealth in cardiology as effective as in-person care?
For monitoring and follow-up of chronic cardiovascular conditions, the evidence is strong. The 2022 AHA scientific statement found telehealth effective for education, diagnosis, monitoring and follow-up in cardiovascular disease. TIM-HF2 showed lower mortality and fewer days lost to hospitalization with structured telemonitoring, and TELESAT-HF reported a 36 percent lower risk of death in a large real-world cohort. Telehealth does not replace imaging, procedures or a physical exam, which is why hybrid models are the norm.
3) Which patients benefit most from telehealth in cardiology?
Patients with heart failure, especially those with a recent hospitalization, are the most studied group and show the clearest mortality and hospitalization benefits. Patients with uncontrolled hypertension see measurable blood pressure improvements with home monitoring and team-based medication management. Rural patients and those far from a cardiologist gain the most in access, since each virtual touchpoint replaces a long trip.
4) What is the status of Medicare telehealth coverage in late 2026?
According to the CMS telehealth FAQ updated in October 2026, the major flexibilities remain in effect through December 31, 2027. Medicare beneficiaries can receive telehealth at home anywhere in the country, audio-only visits are covered in the home, and rural health clinics and FQHCs can serve as distant sites. Without further legislation, most of these provisions revert on January 1, 2028, so practices should check the CMS telehealth page before each plan year.
5) How does remote patient monitoring differ from a telehealth visit?
A telehealth visit is a scheduled, real-time encounter over video or audio. Remote patient monitoring is continuous, with devices sending readings from home that the care team reviews between visits. The two work together: the monitoring data tells the team when a visit is needed, and the visit lets the clinician act on what the data shows. Medicare describes the two under separate requirements, so a practice should review each on its own terms.
6) Do patients need Wi-Fi or a smartphone for telehealth in cardiology?
Video visits require an internet connection and a device with a camera, which is a real barrier for some patients. Remote patient monitoring does not have to. Cellular-connected devices such as Tenovi blood pressure monitors, weight scales and pulse oximeters send readings through the Tenovi Cellular Gateway with no app, pairing or Wi-Fi, so patients without home internet or a smartphone can still be monitored. The 2026 JACC: Advances viewpoints specifically called out this approach as a way to reach underserved communities.
Understanding Telehealth in Cardiology
Telehealth in cardiology combines video visits, remote patient monitoring and hybrid care to manage heart disease between office visits. TIM-HF2 and TELESAT-HF show lower mortality and less time in hospital for heart failure patients under structured telemonitoring, and 2025 hypertension data show systolic reductions of roughly 10 mmHg or more with team-based home monitoring. Rural and underserved patients stand to gain the most when devices work without broadband. Medicare’s telehealth flexibilities run through December 31, 2027, and practices should verify policy with CMS each year. A program succeeds when readings arrive reliably and someone acts on them.
Tenovi provides the remote monitoring infrastructure behind that loop: cellular-connected blood pressure monitors, weight scales, pulse oximeters and other RPM and RTM devices, the Tenovi Cellular Gateway, and device fulfillment, provisioning and support for cardiology practices, health systems and the software platforms that serve them. Devices send readings with no app, pairing or Wi-Fi, so care goes home with the patient. Contact us for a free demo and consultation.
